Mechanical Characterization of Tricuspid Bicuspidization in a Porcine Model by Pataky, Joshua
 
i 
MECHANICAL CHARACTERIZATION OF TRICUSPID 














































 I wish to thank Dr. Wei Sun and the Tissue Mechanics Lab for guidance and the 
opportunity to complete this thesis. I would also like to thank graduate student Fatiesa 

















TABLE OF CONTENTS 
Page 
ACKNOWLEDGEMENTS ii 
LIST OF FIGURES iv 
SUMMARY v 
CHAPTER 
1 Introduction 1 
2 Methods and Materials 3 
Heart Preparation 3 
Chamber Design 3 
Cinching Procedure 4 
Data Analysis 5 
3 Results 6 
4 Discussion 9 
5 Conclusion 11 




LIST OF FIGURES 
Page 
Figure 1: Bicuspidization set-up and heart preparation 4 
Figure 2: Cinching tension and annular area over the cinching length 7 
Figure 3: Tricuspid annular area and diastolic leakage reduction 7 
Figure 4: Representative annular area plots at uncinched and max cinched points 8 












Tricuspid valve regurgitation currently affects over 1.6 million people in the US 
and largely uses annuloplasty ring deployment as the main method of correction for 
severe regurgitation. As this method inherently contains a number of risks, among others, 
the Kay bicuspidization procedure has been adapted for use as a transcatheter device. 
This procedure places anchors in the valve annulus on either side of the posterior leaflet 
and cinches them together, creating a bicuspid valve. The mechanics involved in this 
bicuspidization process, however, are poorly understood; this study looks to quantify 
those mechanics. Paired healthy and regurgitant porcine hearts were attached to a custom 
chamber, with regurgitation being induced through the topical application of 95% phenol. 
Tricuspid valve annular area, diastolic leakage, cinching tension, and annulus ellipticity 
are quantified at different cinching distances. As predicted, the use of phenol to induce 
tricuspid regurgitation is seen to be effective. The bicuspidization cinching reduces 
annular area and diastolic leakage in diseased case hearts to that of a “healthy” heart 









 The heart contains four valves, the aortic, pulmonary, mitral, and tricuspid, which 
ensure unidirectional blood flow through the heart and thus the body. These valves are 
categorized as semilunar valves, the aortic and pulmonary, or atrioventricular valves, the 
mitral and tricuspid. The tricuspid valve (TV) separates the right atrium from the right 
ventricle and is made up of three leaflets, the anterior, posterior, and septal1. The TV 
annulus, the area surrounding the valve, is highly flexible and can lose its shape due to 
physical trauma, right ventricle dilation, or diseases such as rheumatic fever or infective 
endocarditis.  This leads to improper valve closure, or coaptation of the leaflets, and a 
backflow of blood through the TV, known as tricuspid regurgitation (TR)2. TR presents 
itself in two forms: primary, where a lesion or damage to the valve structure causes the 
improper leaflet closure, or functional, where dilation of the annulus and right ventricle 
cause improper leaflet coaptation and thus regurgitant flow3. When left untreated, 
tricuspid regurgitation can cause significant cardiac remodeling which eventually leads to 
heart failure and death4.  
TR affects 1.6 million individuals in the United States and has a very poor one-
year survival rate of 63.9% when at moderate to severe levels5. TR presents no visible 
symptoms until reaching severe levels, often resulting in late diagnosis. When this 
diagnosis does eventually come, patients are likely too high-risk to undergo the corrective 
surgery that is needed3.  
When tricuspid regurgitation becomes too severe to be corrected with medication, 
surgical procedures are employed. The current gold standard involves the implantation of 
an annuloplasty ring to bring the valve annulus back to a normal shape and reduce its 
area, allowing the leaflets to close properly6,7. While annuloplasty surgeries are effective 
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at reducing regurgitation, there is an inherent amount of risk associated with open-heart 
surgery. Additionally, due to the late diagnosis of TR, patients are not approved to 
undergo this open-heart procedure. To combat this risk and treat these unapproved 
patients, several transcatheter devices are currently under development that are based on 
various corrective methods, including the surgical annuloplasty, edge-to-edge leaflet 
repair, and valve bicuspidization. The Kay bicuspidization procedure, which has been 
adapted for percutaneous use in the Trialign procedure8 and is the method used here, 
cinches the TV at the posterior leaflet, turning the three-leaflet valve into a two-leaflet, or 
bicuspid, valve9.  
The bicuspidization procedure has been seen to be effective at reducing tricuspid 
regurgitation in preliminary clinical trials and compassionate use cases4,8,10. The 
mechanics involved of this procedure however have not been studied and it is important 
for medical professionals to have a full understanding of this corrective method. The goal 
of this study is to quantify the mechanics and planar geometry of the TV annulus 
involved in the Kay procedure. The bicuspidization will be replicated through the use of a 
novel ex-vivo testing technique and a custom-designed apparatus. To account for the lack 
of rhythmic contractions, hearts will be placed in contractile and relaxing solutions to 
simulate both active and passive contraction states. Cinching tension, tricuspid annulus 
area (TAA), diastolic leakage (DL), and ellipticity are all recorded during testing to be 
used in gaining a better understanding of this corrective method. 
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CHAPTER 2 
METHODS AND MATERIALS 
 
Heart Preparation 
Adult porcine hearts (n = 12) were obtained from a local slaughterhouse 
(Holifield Farms, Covington, GA) and placed in a 100mM KCl (n = 6) or passive EDTA 
(n = 6) solution until testing could be performed, replicating active and passive states of 
the heart respectively. To perform the bicuspidization procedure, the tricuspid valve was 
first prepared before the heart was attached to the testing chamber. The tricuspid valve 
was exposed by removal of the atria, and optical markers were placed around the 
tricuspid annulus for area tracking. Two cinching sutures were implanted in the tricuspid 
annulus, 3 cm apart on either side of the posterior leaflet, 5 mm superior to the leaflet 
attachment edge, as per the Trialign procedure8.  
Chamber Design 
The chamber design used was custom-built to prevent any alteration to the natural 
geometry of the TV or compromise the pressurization of the right ventricle. As can be 
seen in figure 1, the heart was mounted to the chamber through the left ventricle and was 
hydrostatically pressurized to 25 mmHg through the pulmonary artery to close the TV. 
After the heart was mounted inside the chamber, the cinching lines were anchored to a 
unidirectional slider with a coupled force sensor to measure the tension over the cinching 
distance. When attaching the cinching lines to the slider, care was taken to ensure the 
force applied was acting uniaxially when cinching. As porcine heart sizes vary, the pulley 
system used was made to be adjustable, allowing it to sit as close to the cinching lines as 
possible and obtain accurate tension results regardless of heart size and shape. One 
camera was placed with its lens in plane with the TV annulus to track annular area, while 
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another was used to track DL by the water volume drop used to pressurize the right 
ventricle over the course of the bicuspidization. 
 
Figure 1: Testing set-up and heart before and after mounting to the chamber. A. The heart mounted in the 
chamber. The bar used to vary the location of the pulley can be seen along with the slider to ensure a 
unidirectional force is applied. B. Close-up view of the heart mounted to the chamber. Wires used to mount 
the heart are connected to the left ventricle (LV) to maintain integrity of the right ventricle. C. The heart 
before mounting. The two cinching lines implanted in the annulus and the graphite markers can clearly be 
seen. The pulmonary trunk, which is used for hydrostatic pressurization, is also visible. 
 
Cinching Procedure 
Over the course of the bicuspidization cinch, annular area was measured through 
recording of the optical markers around the annulus. Additionally, diastolic leakage was 
measured by quantification of the change in volume in the water column over time. As 
the cinching distance increased, the force applied to the cinching lines was recorded 
through a custom LabView VI. After initial pressurization, measurements were taken at 
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cinching distances of 1, 2, 3, and 4 cm. After the experiment was completed in the 
healthy porcine heart, 95% phenol, which has been shown to effectively induce TR10, was 
topically applied and the procedure was repeated for the diseased, regurgitant case. Video 
analysis was again performed to capture TAA and DL measurements at each cinching 
distance. Matlab and Excel were used to quantify the annular area, diastolic leakage, and 
cinching tension. 
Data Analysis 
 Data obtained for TAA, DL, and cinching tension is reported as mean ± standard 
deviation, with statistical significance determined by the analysis of variance test and a 
post-hoc t-test. TAA was obtained through video recorded of the TV annulus, DL by 
measuring water drop in the pressurization tube through the valve, and tension recorded 
by the load cell on the unidirectional slider. To analyze the planar geometry of the valve 
during the bicuspidization, the ellipticity was tracked by relating the valve’s large and 
small radii through the equation:  (Equation 1). When e approaches 






Tested hearts were split into four distinct groups: Active Healthy (n = 6), Active 
TR (n = 6), Passive Healthy (n = 6), and Passive TR (n = 6) depending on whether they 
were placed in KCL or EDTA solutions and if testing was done before or after phenol 
application. To ensure TR was effectively induced by topical phenol application, TAA 
dilation was evaluated, with the target being a 25% increase. For the passive hearts, the 
are increased by 22.5 ± 6.1%, while in the active hearts area increased by 27.2 ± 3.0%. 
When looking at the DL increase between healthy and TR hearts, it increased by a factor 
of 4.34 ± 0.74 and 4.44 ± 1.8 for the passive and active hearts, respectively. 
 
The cinching was performed at 1 cm increments over a total distance of 4 cm, 
resulting in 5 points of data collection for each heart in the four groups. As can be seen in 
figure 2, the maximum cinching tension was comparable between all cases, resulting in 
no statistically significant difference between the groups. There was, however, a 
statistically significant increase in TAA at all cinching distances but one between the 
healthy and TR cases in the active and passive states. Over the 4cm cinch, normalized 
annular area decreased in the active TR cases by 21.1% and in the passive TR cases by 
19.0%, bringing the TAA to not significant differences when compared to the uncinched 
hearts in the healthy cases. This decrease in annular area over the course of the cinch led 
to a decrease in recorded diastolic leakage in both the active and passive TR cases, 




Figure 2: Cinching tension and annular area measurements at each cinching distance over the 4cm cinch 
used in bicuspidization of the TV. (*) indicated a statistically significant difference between the healthy and 
TR cases (p<0.05). A: Cinching tension of the passive hearts at cinching lengths. B: Cinching tension of 
the active hearts at cinching lengths. C: Annular area of the passive hearts normalized by the healthy 
uncinched area. D: Annular area of the active hearts normalized by the healthy uncinched area.  
 
 
Figure 3: Tricuspid annulus area and diastolic leakage reduction after bicuspidization of TV. (*) indicate 
p<0.05, 
 
Data from one heart sample in each of the active and passive cases is shown in 
figure 4 as a representation of the TAA data obtained during the bicuspidization cinching 
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procedure. Plotted is the annular area of the uncinched and max cinched annulus area in 
both the healthy and TR states. 
 
Figure 4: Plots of representative TV annular area at uncinched and maximum cinched distances. A) Active 
KCl case annular area. B) Passive EDTA case annular area. 
 
While bicuspidizing the TV it was noticed that the shape of the valves’ annulus 
become more circular and the cinching distance increased. The ellipticity (Fig 5) at the 
maximum cinching distance was significantly lower than when uncinched (p = 0.04 for 
passive healthy, p = 0.01 for passive TR, and p = 0.01 for active healthy) for all groups 
but the active TR case (p = 0.10).  Topically applying phenol to induce TR did not 
significantly change the ellipticity of the annulus, with p = 0.27 for passive states and p = 
0.40 for active states. 
 




The increase in TAA seen in both the active and passive TR cases shows that this 
method of regurgitation induction is effective and can be used when creating a porcine 
model of moderate TR, seen as an increase of 25%. The resulting increase in DL due to 
this increase in annular area in both the active in passive states was substantial. By 
topically applying phenol to dilate the annulus, functional TR was induced, rather than 
using trauma to increase regurgitant flow and causing primary TR. As FTR is the more 
common type of regurgitation, this model will be more impactful when used in 
developing corrective devices.  
Porcine hearts used in this study varied greatly in size, making it crucial to 
normalize the annular area between all samples for an accurate comparison. Uncinched 
annular area ranged from 7cm2 to 13cm2 in size. The normalization factor used was the 
annular area of the uncinched healthy case of each heart. At maximum cinching distance 
in the TR cases, TAA was decreased to levels that are seen in normal healthy hearts, 
showing that this method of FTR correction is effective at reducing the dilation causing 
the regurgitation. This decrease in area also resulted in a significant decrease in leakage 
through the valve. Not only was the annular area decreased by the cinch, but the volume 
leaking through was also reduced, showing the effectiveness this method has in 
correcting FTR.  
Despite the various sizes of the hearts and TV annulus areas that were seen in the 
hearts tested, the cinching tension needed to bicuspidize the annulus over a maximum 
distance of 4 cm had no significant difference between the healthy and TR cases. While 
this was done outside the body without heart contractions, by replicating the active and 
passive states seen in the cardiac cycle, it is believed that these tension values obtained 
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would remain comparable when the bicuspidization is performed in a living, contracting 
heart.  
While the change in annular geometry was noticeable visually during the 
bicuspidization, calculating the ellipticity showed the annulus becoming significantly 
more circular in all groups tested but the active TR hearts. The natural shape of the TV 
annulus is elliptical in the 2D plane, which this procedure is drastically changing. It is 
important to note the topical application of phenol did not significantly alter the geometry 









The approach used in this study creates an effective model of functional tricuspid 
regurgitation in porcine hearts by increasing the annular area and the diastolic leakage 
through the tricuspid valve by topical application of 95% phenol to the annulus. The 
application of phenol effectively increased the annular area to the threshold of a 25% 
increase for what is considered moderate functional tricuspid regurgitation. Additionally, 
the custom device setup used to replicate the bicuspidization procedure not only 
accurately functions but does so in both the passive and active states of the heart, as 
replicated by the use of contractile KCl and relaxing EDTA solutions to soak the hearts in 
pre-cinching. In both these states, the force needed to reach maximum cinching is 
comparable, meaning this procedure will not differ when performed in vivo. At 
maximum cinch of the TR case, annular area was brought back to the range of a healthy 
heart before cinching, showing the effectiveness of this method in eliminating the 
annulus dilation seen in TR. The DL was significantly reduced as well at the maximum 
cinching distance. The geometry of the TV annulus however was greatly altered in shape, 
becoming more circular than the natural elliptical shape, which could alter the flow of 





The sample size used in this study was relatively small, so more samples would 
increase the statistical power. Observing the coaptation of the newly bicuspidized valve is 
crucial for fully understanding the resulting valve anatomy from this procedure. µCT 
imaging can be used to observe and measure leaflet coaptation before and after cinching 
of the TV with pre and post scan comparisons. This will also show the 3D shape of the 
valve, rather than simply looking at the planar geometry as done here. Additionally, while 
porcine hearts are a good stand-in for human hearts, more impactful and clinically 
relevant results could be obtained if this bicuspidization procedure is replicated in a 
human heart model. Finally, while topical application of phenol increased TAA to levels 
seen in moderate TR, the mechanical properties of the tissue could have been altered, 
potentially skewing results. Testing hearts with naturally occurring TR would eliminate 
the need for inducing it and thus preventing this limitation. As seen by the results 
presented here, either the passive or active state could be used to test in a human heart 
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